Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) is anticipated to post its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of $0.18 per share and revenue of $119.3860 million for the quarter. Interested persons are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the call scheduled for Thursday, November 6, 2025 at 5:00 PM ET.
Nature’s Sunshine Products Stock Up 2.1%
Shares of NATR opened at $13.76 on Tuesday. The stock has a market cap of $242.67 million, a P/E ratio of 18.59 and a beta of 1.12. The business’s fifty day moving average is $15.59 and its 200 day moving average is $14.96. Nature’s Sunshine Products has a 12-month low of $11.01 and a 12-month high of $18.06.
Wall Street Analysts Forecast Growth
NATR has been the subject of several analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Nature’s Sunshine Products in a research note on Wednesday, October 8th. DA Davidson set a $21.00 price target on Nature’s Sunshine Products in a research report on Tuesday, October 21st. Finally, Canaccord Genuity Group lifted their price objective on shares of Nature’s Sunshine Products from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $21.50.
Insider Transactions at Nature’s Sunshine Products
In related news, CAO Jonathan David Lanoy sold 5,000 shares of Nature’s Sunshine Products stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $16.51, for a total value of $82,550.00. Following the sale, the chief accounting officer owned 50,051 shares of the company’s stock, valued at approximately $826,342.01. The trade was a 9.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Nathan G. Brower sold 9,996 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $16.54, for a total value of $165,333.84. Following the completion of the transaction, the executive vice president owned 48,277 shares in the company, valued at approximately $798,501.58. The trade was a 17.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 24,668 shares of company stock worth $409,803 in the last quarter. Insiders own 4.70% of the company’s stock.
Institutional Investors Weigh In On Nature’s Sunshine Products
Several institutional investors have recently added to or reduced their stakes in NATR. Bank of America Corp DE lifted its position in shares of Nature’s Sunshine Products by 71.1% during the second quarter. Bank of America Corp DE now owns 43,937 shares of the company’s stock worth $650,000 after acquiring an additional 18,259 shares in the last quarter. Ameriprise Financial Inc. grew its holdings in Nature’s Sunshine Products by 1.4% during the 2nd quarter. Ameriprise Financial Inc. now owns 54,008 shares of the company’s stock valued at $799,000 after buying an additional 753 shares in the last quarter. Sei Investments Co. bought a new stake in shares of Nature’s Sunshine Products during the second quarter valued at about $314,000. Marshall Wace LLP lifted its holdings in shares of Nature’s Sunshine Products by 397.8% in the second quarter. Marshall Wace LLP now owns 82,967 shares of the company’s stock worth $1,227,000 after buying an additional 66,300 shares in the last quarter. Finally, First Trust Advisors LP boosted its position in shares of Nature’s Sunshine Products by 3.4% in the second quarter. First Trust Advisors LP now owns 39,099 shares of the company’s stock valued at $578,000 after acquiring an additional 1,271 shares during the period. 79.40% of the stock is owned by hedge funds and other institutional investors.
Nature’s Sunshine Products Company Profile
Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Featured Stories
- Five stocks we like better than Nature’s Sunshine Products
- Best Energy Stocks – Energy Stocks to Buy Now
- Is Starbucks Quietly Setting Up for a Major 2026 Comeback?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- The Best Local Butchers for Thanksgiving [2025 Survey]
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
